Analysen von Asad Haider
| 11.03.26 | BioNTech (ADRs) Buy | Goldman Sachs Group Inc. | |
| 04.02.26 | Eli Lilly Buy | Goldman Sachs Group Inc. | |
| 04.02.26 | Pfizer Neutral | Goldman Sachs Group Inc. |
| 11.03.26 | BioNTech (ADRs) Buy | Goldman Sachs Group Inc. | |
| 04.02.26 | Eli Lilly Buy | Goldman Sachs Group Inc. | |
| 04.02.26 | Pfizer Neutral | Goldman Sachs Group Inc. |